Login / Signup

Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trials.

Mirko CapannaAlessio SignoriMaria Pia Sormani
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
This study showed that the benefit of treating patients with PMS was mostly confined to those with the more active disease. Drugs targeting specific pathological processes leading to disability progression remain necessary.
Keyphrases
  • multiple sclerosis
  • systematic review
  • clinical trial
  • oxidative stress
  • mass spectrometry
  • open label
  • meta analyses
  • study protocol
  • cancer therapy
  • randomized controlled trial
  • double blind
  • placebo controlled
  • phase iii